STATCenter·
STAT+: Roche continues to look to China for new drugs
China's Hansoh Pharmaceutical Group has announced that it struck a massive deal with Roche to develop a portfolio of antibody-drug conjugates.
Read at STAT →
Health · 1 sources covering this
STAT+: Roche continues to look to China for new drugs
China's Hansoh Pharmaceutical Group has announced that it struck a massive deal with Roche to develop a portfolio of antibody-drug conjugates.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/5c1ab400d6e0342239bfc73524a4789492719c30" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Roche continues to look to China for new drugs"></iframe>
